CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotype

MLA

Wing-Yee Lo, et al. “CYP2C19 Pharmacogenetics in Advanced Cancer: Compromised Function Independent of Genotype.” British Journal of Cancer, vol. 99, Oct. 2008, pp. 1251–55. EBSCOhost, https://doi.org/10.1038/sj.bjc.6604699.

APA

Wing-Yee Lo, K Spells, M Dzhelai, Melissa Murray, Andrew Simpson, Michael Findlay, G. Riley, Nuala A. Helsby, & Katrina Sharples. (2008). CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotype. British Journal of Cancer, 99, 1251–1255. https://doi.org/10.1038/sj.bjc.6604699

Chicago

Wing-Yee Lo, K Spells, M Dzhelai, Melissa Murray, Andrew Simpson, Michael Findlay, G. Riley, Nuala A. Helsby, and Katrina Sharples. 2008. “CYP2C19 Pharmacogenetics in Advanced Cancer: Compromised Function Independent of Genotype.” British Journal of Cancer 99 (October): 1251–55. doi:10.1038/sj.bjc.6604699.